Imidazole derivatives for treatment of allergic and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4164 (2006.01) A61P 11/06 (2006.01) A61P 35/00 (2006.01) A61P 37/08 (2006.01) C07D 233/00 (2006.01)

Patent

CA 2521841

The preferred embodiments are directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. The preferred embodiments also relate to imidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. The preferred embodiments further relate to small molecules which suppress cytokines and leukocytes.

Dans ses modes de réalisation préférés, cette invention concerne des inhibiteurs de petites molécules de la réaction IgE à des allergènes, utiles dans le traitement d'allergies et/ou d'asthmes ou n'importe quelle maladie dans laquelle l'IgE est pathogène. Ces modes de réalisation préférés concernent également des molécules imidazole qui sont des inhibiteurs de prolifération cellulaire et donc utiles en tant qu'agents anticancéreux. Ces modes de réalisation concernent enfin des petites molécules qui suppriment les cytokines et les leucocytes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazole derivatives for treatment of allergic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole derivatives for treatment of allergic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives for treatment of allergic and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1970101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.